Tuberculosis Research Today is a free monthly online journal that collates and summarizes the latest research about Tuberculosis, including details on symptoms, causes, treatment, pulmonary, mycobacterium.

Volume 2 (2005), Issue 1 (January)

1. Macular edema as the only ocular finding of tuberculosis.
   Am J Ophthalmol, 138(6): 1048-9. [Abstract] [Full-text]
2. Intracellular macrophage growth rates and cytokine profiles of Mycobacterium tuberculosis strains with different transmission dynamics.
   J Infect Dis, 191(3): 453-60. [Abstract] [Full-text]
3. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8.
   J Infect Dis, 191(3): 324-32. [Abstract] [Full-text]
4. Gene expression diversity among Mycobacterium tuberculosis clinical isolates.
   Microbiology, 151: 5-14. [Abstract] [Full-text]
5. Multiplex PCR-identified cutaneous tuberculosis evoked by Mycobacterium bovis BCG vaccination in a healthy baby.
   J Clin Microbiol, 43(1): 523-5. [Abstract] [Full-text]
6. Use of variable-number tandem-repeat typing to differentiate Mycobacterium tuberculosis Beijing family isolates from Hong Kong and comparison with IS6110 restriction fragment length polymorphism typing and spoligotyping.
   J Clin Microbiol, 43(1): 314-20. [Abstract] [Full-text]
7. Utility of mycobacterial interspersed repetitive unit typing for differentiating multidrug-resistant Mycobacterium tuberculosis isolates of the Beijing family.
   J Clin Microbiol, 43(1): 306-13. [Abstract] [Full-text]
8. Detection and identification of Mycobacterium tuberculosis in joint biopsy specimens by rpoB PCR cloning and sequencing.
   J Clin Microbiol, 43(1): 174-8. [Abstract] [Full-text]
9. Distribution of the Beijing family genotypes of Mycobacterium tuberculosis in Taiwan.
   J Clin Microbiol, 43(1): 95-100. [Abstract] [Full-text]
10. Sensitivities and specificities of spoligotyping and mycobacterial interspersed repetitive unit-variable-number tandem repeat typing methods for studying molecular epidemiology of tuberculosis.
    J Clin Microbiol, 43(1): 89-94. [Abstract] [Full-text]
11. Assessing the serodiagnostic potential of 35 Mycobacterium tuberculosis proteins and identification of four novel serological antigens.
    J Clin Microbiol, 43(1): 57-65. [Abstract] [Full-text]
12. Tuberculosis situation among tribal population of Car Nicobar, India, 15 years after intensive tuberculosis control project and implementation of a national tuberculosis programme.
    Bull World Health Organ, 82(11): 836-43. [Abstract] [Full-text]
13. Annual risk of infection with Mycobacterium tuberculosis.
    Eur Respir J, 25(1): 181-5. [Abstract] [Full-text]
14. Endoscopic third ventriculostomy for chronic hydrocephalus after tuberculous meningitis.
    Surg Neurol, 63(1): 32-4; discussion 34-5. [Abstract] [Full-text]
15. Diagnosis of sputum-scarce HIV-associated pulmonary tuberculosis in Lima, Peru.
    Lancet, 365(9454): 150-2. [Abstract] [Full-text]
16. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study.
    Lancet, 365(9454): 130-4. [Abstract] [Full-text]
17. Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment.
    J Pharm Pharmacol, 57(1): 23-30. [Abstract] [Full-text]
18. Primary tuberculosis of the oral cavity.
    Oral Dis, 11(1): 50-3. [Abstract] [Full-text]
19. Micronutrient malnutrition and wasting in adults with pulmonary tuberculosis with and without HIV co-infection in Malawi.
    BMC Infect Dis, 4(1): 61. [Abstract] [Full-text]
20. Mycobacterium tuberculosis complex differentiation using gyrB-restriction fragment length polymorphism analysis.
    Mem Inst Oswaldo Cruz, 99(7): 745-8. [Abstract] [Full-text]
21. Delays in suspicion and isolation among hospitalized persons with pulmonary tuberculosis at public and private US hospitals during 1996 to 1999.
    Chest, 127(1): 205-12. [Abstract] [Full-text]
22. Results of nonsurgical treatment of thoracic spinal tuberculosis in adults.
    Spine J, 5(1): 79-84. [Abstract] [Full-text]
23. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.
    Science, 307(5707): 223-7. [Abstract] [Full-text]
24. Retroperitoneal perforation of the colon caused by colonic tuberculosis: report of a case.
    Dis Colon Rectum, 47(12): 2211-4. [Abstract] [Full-text]
25. High prevalence of hepatitis B virus infection among tuberculosis patients with and without HIV in Rio de Janeiro, Brazil.
    Eur J Clin Microbiol Infect Dis, 24(1): 41-3. [Abstract] [Full-text]
26. Spinal tuberculosis: with reference to the children of northern India.
    Childs Nerv Syst, 21(1): 19-26. [Abstract] [Full-text]
27. Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis.
    Vaccine, 23(11): 1393-8. [Abstract] [Full-text]
28. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis.
    Vaccine, 23(11): 1326-34. [Abstract] [Full-text]
29. Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis.
    Infect Immun, 73(2): 1196-203. [Abstract] [Full-text]
30. Phagosomal processing of Mycobacterium tuberculosis antigen 85B is modulated independently of mycobacterial viability and phagosome maturation.
    Infect Immun, 73(2): 1097-105. [Abstract] [Full-text]
31. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study.
    Lancet, 365(9456): 318-26. [Abstract] [Full-text]
32. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment.
    BMC Public Health, 4: 68. [Abstract] [Full-text]
33. Late occurrence of bilateral tuberculous-like epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma.
    Urology, 65(1): 175. [Abstract] [Full-text]
34. Significance of Fas and Fas ligand in tuberculous lymphadenitis.
    Immunology, 114(2): 255-62. [Abstract] [Full-text]
35. Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice.
    Gene Ther, 12(3): 281-7. [Abstract] [Full-text]
36. Frequency of tuberculosis in haematological malignancies and stem cell transplant recipients.
    J Coll Physicians Surg Pak, 15(1): 30-3. [Abstract] [Full-text]
37. Management of bilateral fallopian tube carcinoma coexistent with tuberculous salpingitis.
    J Obstet Gynaecol Res, 31(1): 65-7. [Abstract] [Full-text]
38. Modeling in vivo pharmacokinetics and pharmacodynamics of moxifloxacin therapy for Mycobacterium tuberculosis infection by using a novel cartridge system.
    Antimicrob Agents Chemother, 49(2): 853-6. [Abstract] [Full-text]
39. Tuberculosis in contacts need not indicate disease transmission.
    Thorax, 60(2): 136-7. [Abstract] [Full-text]
40. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia.
    Thorax, 60(2): 130-5. [Abstract] [Full-text]
41. Tuberculin response in BCG vaccinated schoolchildren and the estimation of annual risk of infection in Hong Kong.
    Thorax, 60(2): 124-9. [Abstract] [Full-text]
42. Improving peptide-based assays to differentiate between vaccination and Mycobacterium bovis infection in cattle using nanoparticle carriers for adsorbed antigens.
    J Control Release, 102(3): 551-61. [Abstract] [Full-text]
43. Management of craniovertebral junction tuberculosis.
    Surg Neurol, 63(2): 101-6; discussion 106. [Abstract] [Full-text]
44. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.
    Rheumatology (Oxford), 44(2): 247-50. [Abstract] [Full-text]

© 2004-2008 Tuberculosis Research Today. All Rights Reserved.